Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 17Colorectal Neoplasms 14Neoplasms 13Carcinoma, Hepatocellular 11Prostatic Neoplasms 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Disease 4Stomatitis 3Recurrence 3Pancreatic Neoplasms 3Myeloproliferative Disorders 3Lymphoma 3HIV Infections 3Depression 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Sarcoma 2Postoperative Complications 2Pilonidal Sinus 2

Interventions

Lisaftoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Leukemia, Promyelocytic, Acute × 90 days × Clear all
NCT07597941 2026-06-04

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

The Affiliated People's Hospital of Ningbo University

Phase 2/3 Not yet recruiting
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡